Management of Acute Kidney Injury in Pre-eclampsia

Initial Management

The American College of Cardiology recommends promptly identifying the cause of AKI through careful assessment of volume status, laboratory tests, and exclusion of other causes 2, 3
Discontinue all nephrotoxic medications, especially NSAIDs, which can worsen kidney function, as recommended by the American Heart Association 1, 4
Hold diuretics and adjust beta-blockers to prevent further compromise of renal perfusion, according to the European Society of Cardiology 1, 5
Maintain fluid balance targeting euvolemia with careful monitoring to avoid pulmonary edema, as suggested by the American College of Cardiology 1, 3
Limit total fluid intake to 60-80 mL/h to avoid risks of pulmonary edema while ensuring adequate renal perfusion, as recommended by the American Heart Association 1

Control blood pressure with appropriate antihypertensive medications, such as methyldopa and labetalol, as recommended by the European Society of Cardiology 6, 1
Consider magnesium sulfate for seizure prophylaxis, but use cautiously in renal impairment, as suggested by the American College of Obstetricians and Gynecologists 1

Delivery is the only definitive treatment for pre-eclampsia and associated AKI, as recommended by the European Society of Cardiology 6
The timing of delivery should balance maternal and fetal risks, according to the American College of Obstetricians and Gynecologists 6

Monitor blood pressure at least every 4-6 hours for at least 3 days postpartum, as recommended by the American Heart Association 1
Continue antihypertensive medications postpartum and taper slowly only after days 3-6, as suggested by the American College of Cardiology 1
Avoid NSAIDs for pain management in women with pre-eclampsia who developed AKI, and use acetaminophen as the first-line analgesic, as recommended by the American College of Obstetricians and Gynecologists 4

All women with pre-eclampsia and AKI should be reviewed at 3 months postpartum to ensure normalization of blood pressure, urinalysis, and laboratory tests, as recommended by the American Heart Association 1
Risk stratification based on AKI severity should guide the timing of outpatient follow-up, according to the American Society of Nephrology 2, 7
Long-term cardiovascular and renal monitoring is essential as these women have increased risk of future cardiovascular disease, as suggested by the American College of Cardiology 1